دورية أكاديمية

Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G

التفاصيل البيبلوغرافية
العنوان: Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G
المؤلفون: Kristina Borochova, Katarzyna Niespodziana, Katarina Stenberg Hammar, Marianne van Hage, Gunilla Hedlin, Cilla Söderhäll, Margarete Focke-Tejkl, Rudolf Valenta
المصدر: Vaccines, Vol 8, Iss 2, p 337 (2020)
بيانات النشر: MDPI AG, 2020.
سنة النشر: 2020
المجموعة: LCC:Medicine
مصطلحات موضوعية: respiratory syncytial virus (RSV), glycoprotein protein, recombinant proteins, G protein, epitope, antibody response, Medicine
الوصف: Respiratory syncytial virus (RSV) infections are a major cause of serious respiratory disease in infants. RSV occurs as two major subgroups A and B, which mainly differ regarding the surface glycoprotein G. The G protein is important for virus attachment and G-specific antibodies can protect against infection. We expressed the surface-exposed part of A2 strain-derived G (A2-G) in baculovirus-infected insect cells and synthesized overlapping peptides spanning complete A2-G. The investigation of the natural IgG response of adult subjects during a period of one year showed that IgG antibodies (i) recognize G significantly stronger than the fusion protein F0, (ii) target mainly non-conformational, sequential peptide epitopes from the exposed conserved region but also buried peptides, and (iii) exhibit a scattered but constant recognition profile during the observation period. The IgG subclass reactivity profile (IgG1 > IgG2 > IgG4 = IgG3) was indicative of a mixed Th1/Th2 response. Two strongly RSV-neutralizing sera including the 1st WHO standard contained high IgG anti-G levels. G-specific IgG increased strongly in children after wheezing attacks suggesting RSV as trigger factor. Our study shows that RSV G and G-derived peptides are useful for serological diagnosis of RSV-triggered exacerbations of respiratory diseases and underlines the importance of G for development of RSV-neutralizing vaccines.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2076-393X
العلاقة: https://www.mdpi.com/2076-393X/8/2/337Test; https://doaj.org/toc/2076-393XTest
DOI: 10.3390/vaccines8020337
الوصول الحر: https://doaj.org/article/0be2bfc83b8b44aa811a1ef2b64a1fbfTest
رقم الانضمام: edsdoj.0be2bfc83b8b44aa811a1ef2b64a1fbf
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2076393X
DOI:10.3390/vaccines8020337